Kevin J. Wu, M.D.

  1. Pathologist

Publications

  1. Melody M, Parrondo R, Alhaj Moustafa M, Wu K, Menke D, Seim L, Tun HW. Follicular lymphoma associated paraneoplastic myositis. Clin Case Rep. 2020 Oct; 8 (10):2003-2006 Epub 2020 July 23
    View PubMed
  2. Huynh KN, Nguyen BD, Wu KJ. Gastrointestinal: Caval tumor thrombus and duodenal metastasis from endometrial carcinoma. J Gastroenterol Hepatol. 2019 Feb; 34 (2):309 Epub 2018 Aug 22
    View PubMed
  3. Kahn AE, Wu KJ, Thiel DD. Tumefactive Fat Necrosis with Multinucleate Giant Cell Reaction Mimicking Recurrent Renal Cell Carcinoma following Percutaneous Renal Cryoablation. Case Rep Urol. 2019; 2019:1678193 Epub 2019 Feb 26
    View PubMed
  4. Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS. Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma. Int J Cancer. 2018 Feb 15; 142 (4):747-756 Epub 2017 Oct 28
    View PubMed
  5. Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Arnold ML, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS. Coffee consumption and risk of renal cell carcinoma. Cancer Causes Control. 2017 Aug; 28 (8):857-866 Epub 2017 June 24
    View PubMed
  6. Robinson JL, Tzou KS, Parker AS, Heckman MG, Wu KJ, Hilton TW, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Buskirk SJ. GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer. Br J Radiol. 2017 Jul; 90 (1075):20170174 Epub 2017 June 16
    View PubMed
  7. Heckman MG, Robinson JL, Tzou KS, Parker AS, Wu KJ, Hilton TW, Howat WJ, Miller JL, Kreinest PA, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Carroll JS, Buskirk SJ. An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. PLoS One. 2016; 11 (3):e0151785 Epub 2016 Mar 17
    View PubMed
  8. Sood N, Swaika A, Hanooshi B, Waldorf J, Peterson J, Wu K, Attia S, Dinh TA. High Grade Leiomyosarcoma Mimicking a Recurrent Angiomyxoma in the Perineum. Rare Tumors. 2015 May 5; 7 (2):5875 Epub 2015 May 19
    View PubMed
  9. Ho TH, Kapur P, Joseph RW, Serie DJ, Eckel-Passow JE, Parasramka M, Cheville JC, Wu KJ, Frenkel E, Rakheja D, Stefanius K, Brugarolas J, Parker AS. Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma. Urol Oncol. 2015 Jan; 33 (1):23.e9-23.e14 Epub 2014 Nov 24
    View PubMed
  10. Gardner FP, Serie DJ, Salomao DR, Wu KJ, Markovic SN, Pulido JS, Joseph RW. c-MET expression in primary and liver metastases in uveal melanoma. Melanoma Res. 2014 Dec; 24(6):617-20.
    View PubMed
  11. Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Eur Urol. 2014 Nov; 66 (5):929-35 Epub 2013 Dec 25
    View PubMed
  12. Jorns J, Thiel DD, Arnold ML, Diehl N, Cernigliaro JC, Wu KJ, Parker AS. Correlation of radiographic renal cell carcinoma tumor volume utilizing computed tomography and magnetic resonance imaging compared with pathological tumor volume. Scand J Urol. 2014 Oct; 48 (5):453-9 Epub 2014 July 03
    View PubMed
  13. Becker MN, Wu KJ, Marlow LA, Kreinest PA, Vonroemeling CA, Copland JA, Williams CR. The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro. Urol Oncol. 2014 Apr; 32 (3):317-26 Epub 2013 Sept 17
    View PubMed
  14. Joseph RW, Parasramka M, Eckel-Passow JE, Serie D, Wu K, Jiang L, Kalari K, Thompson RH, Huu Ho T, Castle EP, Cheville J, Kwon ED, Thompson EA, Parker A. Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma. Cancer Immunol Res. 2013 Dec; 1 (6):378-85 Epub 2013 Aug 29
    View PubMed
  15. von Roemeling CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR, Wu K, Tan WW, Tun HW, Copland JA. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 2013 May 1; 19 (9):2368-80 Epub 2013 Apr 30
    View PubMed
  16. Arnold ML, Thiel DD, Diehl N, Wu KJ, Ames S, Parker AS. Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy. BMC Urol. 2013; 13:52. Epub 2013 Oct 22.
    View PubMed
  17. Hutchinson RC, Wu KJ, Cheville JC, Thiel DD. Prostatic stromal hyperplasia with atypia. Case Rep Urol. 2013; 2013:364124 Epub 2013 May 28
    View PubMed
  18. Heckman MG, Parker AS, Wu KJ, Hilton TW, Ko SJ, Pisansky TM, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. Prostate. 2012 Dec 1; 72 (16):1757-66 Epub 2012 Apr 18
    View PubMed
  19. Vishnu P, Colon-Otero G, Kennedy GT, Marlow LA, Kennedy WP, Wu KJ, Santoso JT, Copland JA. RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. Gynecol Oncol. 2012 Mar; 124 (3):589-97 Epub 2011 Nov 22
    View PubMed
  20. Gandhi GY, Shah AA, Wu KJ, Gupta V, Shoraka AR. Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report. Case Rep Endocrinol. 2012; 2012:185454 Epub 2012 Dec 17
    View PubMed
  21. Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ. Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5):1343-9. Epub 2010 Jul 02.
    View PubMed
  22. Clemens AJ, Thiel DD, Wu KJ. Primary cutaneous T cell lymphoma of the external genitalia. J Urol. 2011 Feb; 185(2):687-8. Epub 2010 Dec 18.
    View PubMed
  23. Cooper SJ, Zou H, Legrand SN, Marlow LA, von Roemeling CA, Radisky DC, Wu KJ, Hempel N, Margulis V, Tun HW, Blobe GC, Wood CG, Copland JA. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma. Oncogene. 2010 May 20; 29 (20):2905-15 Epub 2010 Mar 08
    View PubMed
  24. Tun HW, Marlow LA, von Roemeling CA, Cooper SJ, Kreinest P, Wu K, Luxon BA, Sinha M, Anastasiadis PZ, Copland JA. Pathway signature and cellular differentiation in clear cell renal cell carcinoma. PLoS One. 2010 May 18; 5 (5):e10696
    View PubMed
  25. Parker AS, Heckman MG, Wu KJ, Crook JE, Hilton TW, Pisansky TM, Bernard JR, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75(5):1364-70. Epub 2009 May 21.
    View PubMed
  26. Rodriguez FJ, Mota RA, Scheithauer BW, Giannini C, Blair H, New KC, Wu KJ, Dickson DW, Jenkins RB. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma. Brain Pathol. 2009 Oct; 19 (4):623-9 Epub 2008 Aug 15
    View PubMed
  27. Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak BA, Do KA, Wu KJ, Marlow LA, Wood CG, Copland JA, Walker CL. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res. 2009 Jan 1; 15(1):81-90.
    View PubMed
  28. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, Wood CG, Copland JA. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res. 2007 Aug 15; 13 (16):4740-9
    View PubMed
  29. Amar S, Wu KJ, Tan WW. Sorafenib-induced pancreatitis. Mayo Clin Proc 2007 Apr; 82 (4):521
    View PubMed
  30. Parker AS, Lohse CM, Wu K, Kreinest P, Copland JA, Hilton T, Wehle M, Cheville JC, Blute M. Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma. Hum Pathol. 2007 Mar; 38 (3):453-61 Epub 2006 Dec 22
    View PubMed
  31. Lee S, Desai KK, Iczkowski KA, Newcomer RG, Wu KJ, Zhao YG, Tan WW, Roycik MD, Sang QX. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Res. 2006 Sep; 16(9):750-8.
    View PubMed
  32. Thiel DD, Igel TC, Wu KJ. Sarcomatoid carcinoma of transitional cell origin confined to renal pelvis. Urology. 2006 Mar; 67(3):622.e9-11. Epub 2006 Feb 28.
    View PubMed
  33. Thiel DD, Broderick GA, Wu KJ. Inclusion cyst and graft contraction in Tutoplast human cadeveric pericardium following Peyronie's grafting: a previously unreported complication. Int J Impot Res. 2005 Nov-Dec; 17(6):550-2.
    View PubMed
  34. Petrou SP, Pinkstaff DM, Wu KJ, Bregg KJ. Leukoplakia of the bladder. Infections in Urology. 2003 Nov/Dec; 16(4):95-102.
  35. Marks DL, Dominguez M, Wu K, Pagano RE. Identification of active site residues in glucosylceramide synthase. A nucleotide-binding catalytic motif conserved with processive beta-glycosyltransferases. J Biol Chem. 2001 Jul 13; 276(28):26492-8. Epub 2001 May 3
    View PubMed
  36. Wu K, Leighton JA. Images in clinical medicine. Paclitaxel and cell division. N Engl J Med. 2001 Mar 15; 344(11):815.
    View PubMed
  37. Cheville JC, Wu K, Wu K, Sebo TJ, Cheng L, Riehle D, Lohse CM, Shane V. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma? Cancer. 2000 Feb 1; 88 (3):632-6
    View PubMed
  38. Wu K, Wu K, Tazelaar HD. Pulmonary angiomyolipoma and multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis. Hum Pathol. 1999 Oct; 30 (10):1266-8
    View PubMed
PST-20221821